位置:首页 > 蛋白库 > SPRTN_MOUSE
SPRTN_MOUSE
ID   SPRTN_MOUSE             Reviewed;         497 AA.
AC   G3X912; B2RY42;
DT   03-OCT-2012, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2011, sequence version 1.
DT   03-AUG-2022, entry version 65.
DE   RecName: Full=DNA-dependent metalloprotease SPRTN {ECO:0000305};
DE            EC=3.4.24.- {ECO:0000250|UniProtKB:Q9H040};
DE   AltName: Full=Protein with SprT-like domain at the N terminus {ECO:0000250|UniProtKB:Q9H040};
DE            Short=Spartan {ECO:0000250|UniProtKB:Q9H040};
GN   Name=Sprtn {ECO:0000312|MGI:MGI:2685351};
GN   Synonyms=Gm505 {ECO:0000312|MGI:MGI:2685351};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=25501849; DOI=10.1038/ncomms6744;
RA   Maskey R.S., Kim M.S., Baker D.J., Childs B., Malureanu L.A.,
RA   Jeganathan K.B., Machida Y., van Deursen J.M., Machida Y.J.;
RT   "Spartan deficiency causes genomic instability and progeroid phenotypes.";
RL   Nat. Commun. 5:5744-5744(2014).
RN   [5]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=28199696; DOI=10.1093/nar/gkx107;
RA   Maskey R.S., Flatten K.S., Sieben C.J., Peterson K.L., Baker D.J.,
RA   Nam H.J., Kim M.S., Smyrk T.C., Kojima Y., Machida Y., Santiago A.,
RA   van Deursen J.M., Kaufmann S.H., Machida Y.J.;
RT   "Spartan deficiency causes accumulation of Topoisomerase 1 cleavage
RT   complexes and tumorigenesis.";
RL   Nucleic Acids Res. 45:4564-4576(2017).
RN   [6]
RP   FUNCTION.
RX   PubMed=27871365; DOI=10.1016/j.molcel.2016.09.031;
RA   Stingele J., Bellelli R., Alte F., Hewitt G., Sarek G., Maslen S.L.,
RA   Tsutakawa S.E., Borg A., Kjaer S., Tainer J.A., Skehel J.M., Groll M.,
RA   Boulton S.J.;
RT   "Mechanism and regulation of DNA-protein crosslink repair by the DNA-
RT   dependent metalloprotease SPRTN.";
RL   Mol. Cell 64:688-703(2016).
CC   -!- FUNCTION: DNA-dependent metalloendopeptidase that mediates the
CC       proteolytic cleavage of covalent DNA-protein cross-links (DPCs) during
CC       DNA synthesis, thereby playing a key role in maintaining genomic
CC       integrity (PubMed:28199696, PubMed:27871365). DPCs are highly toxic DNA
CC       lesions that interfere with essential chromatin transactions, such as
CC       replication and transcription, and which are induced by reactive
CC       agents, such as UV light or formaldehyde (PubMed:28199696,
CC       PubMed:27871365). Associates with the DNA replication machinery and
CC       specifically removes DPCs during DNA synthesis. Acts as a pleiotropic
CC       protease for DNA-binding proteins cross-linked with DNA, such as TOP1,
CC       TOP2A, histones H3 and H4 (By similarity). Mediates degradation of DPCs
CC       that are not ubiquitinated, while it is not able to degrade
CC       ubiquitinated DPCs. SPRTN activation requires polymerase collision with
CC       DPCs followed by helicase bypass of DPCs (By similarity). Involved in
CC       recruitment of VCP/p97 to sites of DNA damage. Also acts as an
CC       activator of CHEK1 during normal DNA replication by mediating
CC       proteolytic cleavage of CHEK1, thereby promoting CHEK1 removal from
CC       chromatin and subsequent activation. Does not activate CHEK1 in
CC       response to DNA damage. May also act as a 'reader' of ubiquitinated
CC       PCNA: recruited to sites of UV damage and interacts with ubiquitinated
CC       PCNA and RAD18, the E3 ubiquitin ligase that monoubiquitinates PCNA.
CC       Facilitates chromatin association of RAD18 and is required for
CC       efficient PCNA monoubiquitination, promoting a feed-forward loop to
CC       enhance PCNA ubiquitination and translesion DNA synthesis (By
CC       similarity). {ECO:0000250|UniProtKB:A0A1L8G2K9,
CC       ECO:0000250|UniProtKB:Q9H040, ECO:0000269|PubMed:27871365,
CC       ECO:0000269|PubMed:28199696}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000250|UniProtKB:Q9H040};
CC   -!- ACTIVITY REGULATION: DNA-binding activates the protease activity:
CC       single-stranded DNA-binding specifically activates ability to cleave
CC       covalent DNA-protein cross-links (DPCs). In contrast, double-stranded
CC       DNA-binding specifically activates autocatalytic cleavage, and
CC       subsequent inactivation. {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- SUBUNIT: Homodimer. Interacts (VIA PIP-box) with PCNA (when
CC       ubiquitinated). Interacts (via its SHP-box) with VCP/p97. Interacts
CC       with RAD18. Interacts with KCTD13 and POLD3.
CC       {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:Q9H040}.
CC       Chromosome {ECO:0000250|UniProtKB:Q9H040}. Note=Localizes to sites of
CC       UV damage via the PIP-box. Recruited to stalled replication forks at
CC       sites of replication stress following deubiquitination. CHEK1
CC       stimulates recruitment to chromatin. {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- DOMAIN: The PIP-box mediates the interaction with PCNA, while the UBZ4-
CC       type zinc finger mediates binding to 'Lys-48'- and 'Lys-63'-linked
CC       polyubiquitin. {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- PTM: Autocatalytically cleaved in response to double-stranded DNA-
CC       binding: autocatalytic cleavage takes place in trans and leads to
CC       inactivation. {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- PTM: Monoubiquitinated; monoubiquitination promotes exclusion from
CC       chromatin. Deubiquitinated by VCPIP1: deubiquitination is required for
CC       subsequent acetylation and recruitment to chromatin and DNA damage
CC       sites. {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- PTM: Acetylated following deubiquitination by VCPIP1, leading to
CC       recruitment to chromatin and DNA damage sites.
CC       {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- PTM: Phosphorylation by CHEK1 promotes recruitment to chromatin.
CC       {ECO:0000250|UniProtKB:Q9H040}.
CC   -!- DISRUPTION PHENOTYPE: Embryonic lethality caused by genomic instability
CC       (PubMed:25501849). Cells display impaired lesion bypass, incomplete DNA
CC       replication, formation of micronuclei and chromatin bridges and
CC       eventually cell death (PubMed:25501849). Cells show an accumulation of
CC       DNA-protein cross-links (DPCs) (PubMed:28199696). Sprtn-
CC       haploinsufficient mice are viable but show accelerated aging,
CC       characterized by cataracts, lordokyphosis and cachexia at a young age
CC       (PubMed:25501849). {ECO:0000269|PubMed:25501849,
CC       ECO:0000269|PubMed:28199696}.
CC   -!- SIMILARITY: Belongs to the Spartan family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC139158; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH466525; EDL11789.1; -; Genomic_DNA.
DR   EMBL; BC158088; AAI58089.1; -; mRNA.
DR   CCDS; CCDS52705.1; -.
DR   RefSeq; NP_001104611.1; NM_001111141.1.
DR   AlphaFoldDB; G3X912; -.
DR   SMR; G3X912; -.
DR   BioGRID; 232674; 1.
DR   STRING; 10090.ENSMUSP00000034467; -.
DR   iPTMnet; G3X912; -.
DR   PhosphoSitePlus; G3X912; -.
DR   EPD; G3X912; -.
DR   MaxQB; G3X912; -.
DR   PaxDb; G3X912; -.
DR   PRIDE; G3X912; -.
DR   ProteomicsDB; 257328; -.
DR   Antibodypedia; 20798; 135 antibodies from 19 providers.
DR   Ensembl; ENSMUST00000034467; ENSMUSP00000034467; ENSMUSG00000031986.
DR   GeneID; 244666; -.
DR   KEGG; mmu:244666; -.
DR   UCSC; uc009nxx.2; mouse.
DR   CTD; 83932; -.
DR   MGI; MGI:2685351; Sprtn.
DR   VEuPathDB; HostDB:ENSMUSG00000031986; -.
DR   eggNOG; KOG3931; Eukaryota.
DR   GeneTree; ENSGT00390000003585; -.
DR   HOGENOM; CLU_019426_2_0_1; -.
DR   InParanoid; G3X912; -.
DR   OMA; AYLFITN; -.
DR   OrthoDB; 1171375at2759; -.
DR   PhylomeDB; G3X912; -.
DR   TreeFam; TF314762; -.
DR   Reactome; R-MMU-110320; Translesion Synthesis by POLH.
DR   BioGRID-ORCS; 244666; 22 hits in 107 CRISPR screens.
DR   PRO; PR:G3X912; -.
DR   Proteomes; UP000000589; Chromosome 8.
DR   RNAct; G3X912; protein.
DR   Bgee; ENSMUSG00000031986; Expressed in spermatocyte and 210 other tissues.
DR   GO; GO:0000785; C:chromatin; ISS:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; ISO:MGI.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; ISS:UniProtKB.
DR   GO; GO:0070530; F:K63-linked polyubiquitin modification-dependent protein binding; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004222; F:metalloendopeptidase activity; ISS:UniProtKB.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; IBA:GO_Central.
DR   GO; GO:0003697; F:single-stranded DNA binding; ISS:UniProtKB.
DR   GO; GO:0043130; F:ubiquitin binding; ISS:UniProtKB.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; ISS:UniProtKB.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:0016540; P:protein autoprocessing; ISS:UniProtKB.
DR   GO; GO:0106300; P:protein-DNA covalent cross-linking repair; IMP:UniProtKB.
DR   GO; GO:0006508; P:proteolysis; ISS:UniProtKB.
DR   GO; GO:0009411; P:response to UV; ISS:UniProtKB.
DR   GO; GO:0019985; P:translesion synthesis; ISS:UniProtKB.
DR   InterPro; IPR006642; Rad18_UBZ4.
DR   InterPro; IPR044245; Spartan.
DR   InterPro; IPR006640; SprT-like_domain.
DR   PANTHER; PTHR21220; PTHR21220; 1.
DR   Pfam; PF10263; SprT-like; 1.
DR   SMART; SM00731; SprT; 1.
DR   SMART; SM00734; ZnF_Rad18; 1.
DR   PROSITE; PS51908; ZF_UBZ4; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   2: Evidence at transcript level;
KW   Acetylation; Autocatalytic cleavage; Chromosome; DNA damage; DNA repair;
KW   Hydrolase; Isopeptide bond; Metal-binding; Metalloprotease; Nucleus;
KW   Phosphoprotein; Protease; Reference proteome; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..497
FT                   /note="DNA-dependent metalloprotease SPRTN"
FT                   /id="PRO_0000419484"
FT   DOMAIN          46..213
FT                   /note="SprT-like"
FT                   /evidence="ECO:0000255"
FT   ZN_FING         462..489
FT                   /note="UBZ4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   REGION          344..459
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           254..262
FT                   /note="SHP-box"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   MOTIF           326..333
FT                   /note="PIP-box"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   MOTIF           413..424
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   COMPBIAS        344..364
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        372..410
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        411..430
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        431..459
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        113
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         112
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         116
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         131
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   BINDING         465
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         468
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         480
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   BINDING         484
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01256"
FT   SITE            228..229
FT                   /note="Cleavage; by autolysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   MOD_RES         231
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   MOD_RES         269
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   MOD_RES         384
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   CROSSLNK        304
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   CROSSLNK        342
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   CROSSLNK        342
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   CROSSLNK        362
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   CROSSLNK        432
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H040"
FT   CONFLICT        413
FT                   /note="D -> N (in Ref. 3; AAI58089)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        442
FT                   /note="R -> Q (in Ref. 3; AAI58089)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   497 AA;  55317 MW;  92B47BFBFD4616C6 CRC64;
     MDEDLVVALR LQEEWDVQMA RRAAAAREPV SLVDASWELV DPTPDLQALF LQFNDRFFWG
     QLEAVEVKWS VRMTLCAGIC TYEGRGGMCS IRLSEPLLKL RPRKDLVETL LHEMIHAYLF
     VTNNDKDREG HGPEFCKHMH RINQLTGANI TVYHTFHDEV DEYRRHWWRC NGPCQHRQPY
     YGYVKRATNR APSVHDYWWA DHQKTCGGTY IKIKEPENYS KKGRGKTKAD KQPASAVENK
     DKLCRGEAQL LIPFSGKGYV LGDASTCPSA GKLNTSYMVN EAKGLSSQDH SVSGLRLNSN
     AEVKCEQNCL PKKPHLVSPL PTASHQSVLS SYFPRVSVAN QKAFRNVNGS PVKNGTTGDG
     TKRPASGGSQ RKVPPSRASL RNTSKVTAPA SATVTSAAGT SATISREESG SEDQFLNKRP
     RLEDRTALDT IKEQTQSGGD LRSSSQPTAA SAPQSLSSQR RLVNCPVCQG VVVESQINEH
     LDRCLEGNKT NLRPRRV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024